Shares of Lifevantage Corporation (NASDAQ: LFVN) continued to slump on Friday. After plunging 16 percent in the previous session, shares were losing another 4 percent on Friday. The company announced that it will be recalling and replacing bottles of its Protandim (the Nrf2 Synergizer, dietary supplement) from all affected independent distributors and others customers. The Company said tit was taking this decision as it feels that final product contained small metal fragments.
Firearms maker, Smith & Wesson Holding Corporation (NASDAQ:SWHC) were down 6.70 percent on Friday, even after the company reported that it swung back into profit during fiscal second quarter and raised its outlook on fiscal third quarter and full year earnings, buoyed by strong demand for its entire mix of firearms.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) were plummeting nearly 19 percent. Amarin, a biopharmaceutical company, which specializes on the commercialization and development of therapeutics to improve cardiovascular health, announced that Vascepa (a cholesterol reducing pill) will be commercially launched in the first quarter of 2013. However investors were unhappy from the company as it intends to hire its own sales staff for business development purposes. Investors were hoping the Company would have entered in a partnership agreement by now.
QR Energy LP (NYSE:QRE) was losing nearly 5.5 percent. The Company announced on Friday that it has priced its formerly announced underwritten public offering (the “offering”) of 12,000,000 common units representing limited partner interests in QRE (the “common units”) at a price to the public of $16.24 per common unit. The underwriters have been offered a 30-day option to buy up to an additional 1,800,000 common units. The offering is expected to expire on December 12, 2012, depending on customary closing conditions.
Contrary to expectations, shares of DVD rental and media-streaming company, Netflix Inc. (NASDAQ: NFLX) were gaining Friday. Earlier on Thursday the company disclosed that the Securities and Exchange Commission (SEC) could file a civil lawsuit against the Company as it posted a message on social networking platform Facebook in July which concurrently resulted in Netflix’s biggest gain in last six weeks.
AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) were gaining 5.15 percent. The Company announced that that it has priced its underwritten public offering of 12.5 million common shares at $3.31 per share.
AcelRx Pharmaceuticals, a Pharmaceutical Company, focuses on developing and commercialization of therapies for treating pain. The stock’s 52 week trading range is 3.43 – 3.70.
Harry Winston Diamond Corporation (USA) (NYSE: HWD) was down 2.71 percent of Friday after Company’s Chief Executive Officer, Robert Gannicott, said that Harry Winston Diamond Corp does not intend sell or spin out its watch and jewelry division in the next year, however the retail arm will eventually become a separate unit.
While addressing to investors and analysts in a conference call, the CEO said, “In the fullness of time, it will certainly either become separated or be sold to someone that can do better with it than we would be able to.” On Thursday, following the closing bell, the diamond miner and retailer downwardly revised its outlook on full-year diamond production targets.
Recent Comments